


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+22.23%
+10.11%
+2.46%
TELA
TELA Bio
$1.14
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
TELA Price Performance
$1.23 (-7.32%)
$1.59 (-28.30%)
$2.07 (-44.93%)
$2.77 (-58.84%)
TELA has Medium risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

Low volume

High volatilty

TELA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Reported a weak earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
TELA Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
TELA Street Sentiment is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is TELA current stock price?
What are TELA stock strengths?
What is TELA Risk Level?
What is TELA market cap and volume?
What is TELA current Stock IQ?
Should I buy TELA stock right now?
Is TELA a Strong Buy right now?
What does a 'Strong Buy' rating mean for TELA?
What does a 'Strong Sell' rating mean for TELA?
What factors influence TELA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+22.23%
+10.11%
+2.46%
TELA
TELA Bio
Current Price
$1.14
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market

TELA Price Performance
$1.23 (-7.32%)
$1.59 (-28.30%)
$2.07 (-44.93%)
$2.77 (-58.84%)
TELA Analysts Opinion
TELA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Reported a weak earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
TELA Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
TELA Street Sentiment is unimpressive and have negative views on the near-term outlook
TELA has Medium risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

Low volume

High volatilty

Average key support and resistance price levels
TELA Stock IQ
TELA Latest Analysis
Lake Street Maintains TELA Bio (TELA) Buy Recommendation. Fintel reports that on December 1 2025 Lake Street maintained coverage of TELA Bio (NasdaqGM:TELA) with a Buy recommendation. Analyst Price Forecast Suggests 327.30% Upside
Tue Dec 2, 2025
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference. th Annual Healthcare Conference.
Wed Nov 19, 2025
Canaccord Genuity Maintains TELA Bio (TELA) Buy Recommendation. Fintel reports that on November 18 2025 Canaccord Genuity maintained coverage of TELA Bio (NasdaqGM:TELA) with a Buy recommendation. Analyst Price Forecast Suggests 316.05% Upside
Wed Nov 19, 2025
These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings. TELA) reported mixed results for the third quarter on Thursday.The company posted quarterly losses of 19 cents per share which beat the analyst consensus estimate of losses of 20 cents per share. The company reported quarterly sales of $20.700 million which missed the analyst consensus estimate of $21.788 million.“.We demonstrated continued growth and meaningful progress this quarter resulting from a strengthened leadership t
Fri Nov 14, 2025
Tela Bio outlines at least 16% 2025 revenue growth target while strengthening commercial team and balance sheet.
Thu Nov 13, 2025
TELA Bio Inc. (TELA) Reports Q3 Loss Misses Revenue Estimates. TELA Bio (TELA) delivered earnings and revenue surprises of -11.76% and -5.53% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Thu Nov 13, 2025
TELA Bio GAAP EPS of -$0.19 beats by $0.02 revenue of $20.7M misses by $1.08M.
Thu Nov 13, 2025
TELA Bio prices $13M registered direct offering of common stock pre-funded warrants.
Thu Nov 13, 2025
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants. MALVERN Pa. Nov. 13 2025 (GLOBE NEWSWIRE) -- TELA Bio Inc. (".TELA".) a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions today announced the pricing of an underwritten registered direct offering of 4189000 shares of its common stock at a price of $1.11 per share and in lieu of common stock to investors w
Thu Nov 13, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
TELA Stock trends
TELA Stock performance
TELA Stock analysis
TELA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.